Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Alisson Lynch"'
Autor:
Carolyn Williamson, Alisson Lynch, Gerald K. Chege, Ann E. Meyers, Clive M. Gray, Enid G. Shephard, Edward P. Rybicki, Anna-Lise Williamson, Joanne van Harmelen
Publikováno v:
Journal of General Virology. 89:2214-2227
A DNA vaccine expressing human immunodeficiency virus type 1 (HIV-1) southern African subtype C Gag (pTHGag) and a recombinant baculovirus Pr55gagvirus-like particle prepared using a subtype C Pr55gagprotein (Gag VLP) was tested in a prime–boost in
Autor:
Richard James Halsey, Sirika Pillay, Anna-Lise Williamson, Fiona Lesley Tanzer, Alisson Lynch, Ann E. Meyers, Edward P. Rybicki, Enid G. Shephard
Publikováno v:
Virus Research. 133:259-268
HIV-1 Pr55 Gag virus-like particles (VLPs) are strong immunogens with potential as candidate HIV vaccines. VLP immunogenicity can be broadened by making chimaeric Gag molecules: however, VLPs incorporating polypeptides longer than 200 aa fused in fra
Publikováno v:
Virology Journal
Virology Journal, Vol 9, Iss 1, p 210 (2012)
Virology Journal, Vol 9, Iss 1, p 210 (2012)
Background HIV-1 Pr55gag virus-like particles (VLPs) expressed by baculovirus in insect cells are considered to be a very promising HIV-1 vaccine candidate, as they have been shown to elicit broad cellular immune responses when tested in animals, par
Autor:
Alisson Lynch, Edward P. Rybicki, Enid G. Shephard, Malcolm J. Fraser, Anna-Lise Williamson, Fiona Lesley Tanzer
Publikováno v:
BMC Biotechnology
BMC Biotechnology, Vol 10, Iss 1, p 30 (2010)
BMC Biotechnology, Vol 10, Iss 1, p 30 (2010)
Background Insect baculovirus-produced Human immunodeficiency virus type 1 (HIV-1) Gag virus-like-particles (VLPs) stimulate good humoral and cell-mediated immune responses in animals and are thought to be suitable as a vaccine candidate. Drawbacks t
Autor:
Edward P. Rybicki, Anna-Lise Williamson, Fiona Lesley Tanzer, Alisson Lynch, Enid G. Shephard, Ann E. Meyers, Ereck Chakauya, James Maclean
Publikováno v:
BMC Biotechnology
BMC Biotechnology, Vol 8, Iss 1, p 53 (2008)
BMC Biotechnology, Vol 8, Iss 1, p 53 (2008)
Background Human immunodeficiency virus type 1 (HIV-1) has infected more than 40 million people worldwide, mainly in sub-Saharan Africa. The high prevalence of HIV-1 subtype C in southern Africa necessitates the development of cheap, effective vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d97fece1697e47d9d678596b5dec0e
http://hdl.handle.net/11427/14452
http://hdl.handle.net/11427/14452
Autor:
Waleria Hryniewicz, Sandor Snoeijers, Christa Cuny, Miranda Boers, Janusz Fiett, Christel van der Werken-Libregts, Anneke van der Zee, Nancy Bakker, Wim J. B. Wannet, Tanny van der Reyden, Willem B. van Leeuwen, Daniëlle van der Riet, Max Heck, Anita Tuip, Marc Struelens, Diane Egberink, Mirjam Kooistra, Isabelle Vernez, Ariane Deplano, Kim van der Zwaluw, Elisabeth M. Bik, G. T. Noordhoek, Bjorn Lunter, Dominique S. Blanc, Inge van Duyn, Alisson Lynch, Sebastiaan A. J. Zaat, Sije Mulder, Dick Veenendaal, Nicole H. M. Renders, Jim Landegent, Lenie Dijkshoorn, Monique de Proost, Henri A. Verbrugh, Jan Kluytmans, Barry Cookson, Alex van Belkum, Etty Gits, Wolfgang Witte, Adriaan Talens
Publikováno v:
Journal of Microbiological Methods, 51, 19-28. Elsevier
Journal of microbiological methods, 51(1), 19-28. Elsevier
Journal of microbiological methods, 51(1), 19-28. Elsevier
The reproducibility of the binary typing (BT) protocol developed for epidemiological typing of Staphylococcus aureus was analyzed in a biphasic multicenter study. In a Dutch multicenter pilot study, 10 genetically unique isolates of methicillin-resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af648ce7061f940f4c0d2aa0338c8867
https://pure.eur.nl/en/publications/9070a606-1b28-47db-90fc-b1e9b2b133ea
https://pure.eur.nl/en/publications/9070a606-1b28-47db-90fc-b1e9b2b133ea